Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

With billions of dollars in market value, the psychedelic drug industry has exploded over the past year. Starting in March of 2020, with the listing of MindMed on Canada’s Neo Exchange, there are now over 50 publicly traded companies focusing on psychedelics.  This comes as quite a surprise to new investors discovering the growing psychedelics…

Explaining a psychedelic trip is nearly impossible. Authors, song writers, and filmmakers have tried for years to explain what the whole experience is like, but always fall just short.  However, despite the difficulty to explain what a psychedelic experience is like, there is one thing that nearly everyone agrees on: A psychedelic experience shows how…

The usage of psychedelic drugs as a therapeutic tool will have an enormous payoff for patients who are seeking new ways to cope with mental health issues. But the advancement of psychedelics is also going to have massive payoffs for early investors in companies that provide these therapies. We are already starting to see a…